ArticleFrontiers in pharmacology2022

Canagliflozin Ameliorates NLRP3 Inflammasome-Mediated Inflammation Through Inhibiting NF-κB Signaling and Upregulating Bif-1.

Yaoyun Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.